![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 413/04 | (2006.01) |
A61K 31/4155 | (2006.01) | ||
A61P 37/00 | (2006.01) | ||
A61P 17/06 | (2006.01) | ||
A61P 5/14 | (2006.01) | ||
A61P 1/04 | (2006.01) | ||
A61P 9/10 | (2006.01) |
(11) | Number of the document | 3679034 |
(13) | Kind of document | T |
(96) | European patent application number | 18762111.5 |
Date of filing the European patent application | 2018-09-06 | |
(97) | Date of publication of the European application | 2020-07-15 |
(45) | Date of publication and mention of the grant of the patent | 2022-06-01 |
(46) | Date of publication of the claims translation | 2022-09-12 |
(86) | Number | PCT/EP2018/073993 |
Date | 2018-09-06 |
(87) | Number | WO 2019/048541 |
Date | 2019-03-14 |
(30) | Number | Date | Country code |
17189652 | 2017-09-06 | EP |
(72) |
FELDING, Jakob , DK
KOHLHOF, Hella , DE
GRÖPPEL, Manfred , DE
MÜHLER, Rolf Andreas , DE
VITT, Daniel , DE
CHEVRIER, Carine , DE
ZAJA, Mirko , DE
TASLER, Stefan , DE
|
(73) |
Immunic AG ,
Lochhamer Schlag 21, 82166 Gräfelfing,
DE
|
(74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 1-(4-(Izoksazol-5-il)-1H-pirazol-1-il)-2-metilpropan-2-olio dariniai ir susiję junginiai, kaip IL-7 ir IFN- gama inhibitoriai, skirti autoimuninių ligų ir lėtinių uždegimų gydymui |
1-(4-(ISOXAZOL-5-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS IL-7 AND IFN-GAMMA INHIBITORS FOR TREATING AUTOIMMUNE DISEASES AND CHRONIC INFLAMMATION |
Payment date | Validity (years) | Amount | |
2023-08-24 | 6 | 139.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-09-06 |